Accretion Pharmaceuticals Ltd

Accretion Pha. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Accretion Pharmaceuticals Ltd

₹ 95.5 3.41%
12 Dec - close price
accretionpharma.com NSE - SME: ACCPL
About

Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.[1]

Key Points

Business Profile[1]
The company manufactures pharmaceutical formulations, including both generic and branded products. It offers contract and third-party manufacturing services for domestic and international markets. Its clientele includes private institutions, government sectors (state and central), and reputed pharmaceutical companies.

Website NSE - ST
  • Market Cap ₹ 106 Cr.
  • Current Price ₹ 95.5
  • High / Low ₹ 102 / 53.8
  • Stock P/E 11.7
  • Book Value ₹ 41.9
  • Dividend Yield 0.00 %
  • ROCE 46.4 %
  • ROE 65.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Debtor days have improved from 116 to 74.2 days.
  • Company's working capital requirements have reduced from 127 days to 65.3 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2024 Sep 2024 Mar 2025 Sep 2025
13.35 18.56 38.81 43.74
10.78 14.23 31.27 36.67
Operating Profit 2.57 4.33 7.54 7.07
OPM % 19.25% 23.33% 19.43% 16.16%
0.05 0.02 0.08 0.11
Interest 0.40 0.69 0.74 0.37
Depreciation 0.22 0.37 0.41 0.40
Profit before tax 2.00 3.29 6.47 6.41
Tax % 25.00% 25.23% 33.08% 25.90%
1.49 2.46 4.33 4.75
EPS in Rs 3.72 3.01 5.30 4.27
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2024 Mar 2025 TTM
13.35 57.38 82.55
10.78 45.49 67.94
Operating Profit 2.57 11.89 14.61
OPM % 19.25% 20.72% 17.70%
0.05 0.09 0.19
Interest 0.40 1.44 1.11
Depreciation 0.22 0.77 0.81
Profit before tax 2.00 9.77 12.88
Tax % 25.00% 30.40%
1.49 6.79 9.08
EPS in Rs 3.72 8.31 9.57
Dividend Payout % 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 159%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 130%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 65%

Balance Sheet

Figures in Rs. Crores

Mar 2024 Mar 2025 Sep 2025
Equity Capital 4.00 8.17 11.12
Reserves 1.49 7.12 35.46
13.48 14.10 7.85
8.47 10.48 4.64
Total Liabilities 27.44 39.87 59.07
5.25 6.09 8.67
CWIP 0.00 0.00 0.00
Investments 0.00 0.00 0.00
22.19 33.78 50.40
Total Assets 27.44 39.87 59.07

Cash Flows

Figures in Rs. Crores

Mar 2024 Mar 2025
-11.51 5.75
-5.48 -1.61
17.08 -4.18
Net Cash Flow 0.09 -0.04

Ratios

Figures in Rs. Crores

Mar 2024 Mar 2025
Debtor Days 158.58 74.17
Inventory Days 564.06 188.49
Days Payable 256.32 69.41
Cash Conversion Cycle 466.31 193.25
Working Capital Days 189.47 65.33
ROCE % 46.36%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2025Sep 2025
73.50% 73.52%
2.22% 1.16%
0.09% 0.00%
24.19% 25.33%
No. of Shareholders 1,6281,498

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls